Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya
Status:
Completed
Trial end date:
2016-09-30
Target enrollment:
Participant gender:
Summary
In this study, the investigators aim to evaluate the indirect revascularization outcomes of a
new combination therapy of multiple burrhole procedure with promotion of arteriogenesis by
intravenous (IV) erythropoietin (EPO) pretreatment on Moyamoya patients with acute
neurological presentation, and outline the clinical and vascular factors associated with
revascularization through the burrholes.